drugset / Trial / NCT00755495

Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia

NCT00755495

Phase 2 Completed 472 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy of ramelteon, once daily (QD), combined with doxepin in treating subjects with insomnia.

Timeline

Start
2006-07
Primary completion
2007-03
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxepin Unknown 3 mg Oral
Subject Ramelteon Unknown 8 mg Oral